Advanced testing for unclear cystic fibrosis diagnosis
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study uses advanced diagnostic tests to help people whose cystic fibrosis (CF) diagnosis is unclear. It aims to give a clearer answer about whether you have CF or a related condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older.
- You are either unsure of your CF diagnosis, have confirmed CF, or do not have CF.
- You are willing to have a small tissue sample taken from your rectum (rectal biopsy).
- You do not have a bleeding disorder or take blood thinners that increase bleeding risk.
- You are not pregnant or breastfeeding.
- You are not currently taking a CFTR modulator medication or in a drug trial that affects CFTR function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how lung infections and inflammation affect people with cystic fibrosis during severe flare-ups. It aims to understand which antibiotics work best and why, so your care team can choose the right treatment for you.
This study tests a new method to detect bacteria in the lungs of people with cystic fibrosis (CF) by analyzing mucus samples. It aims to improve how we diagnose and treat lung infections.
This study tests whether people with cystic fibrosis who are already on a triple combination CFTR modulator can stay on their treatment without interruptions or problems. It aims to make sure everyone gets the best, most consistent treatment for their CF.
This trial is for people whose newborn screening for cystic fibrosis left some uncertainty. It looks at those with an unclear sweat test or genetic findings that don't fully confirm CF, to better understand their health and needs.
This study looks for simple signals (markers) that may show whether cystic fibrosis treatments are working. It includes people who take CF “modulator” medicines like ivacaftor, people who don’t, and people whose cystic fibrosis was ruled out after testing.
This study collects cells from people with cystic fibrosis (CF) caused by rare CFTR gene changes. The goal is to build a cell bank for future research, which may help scientists develop better tests and treatments for rare CF types.
Hear when a new Cystic Fibrosis (CF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.